Stock Code: 002370 Stock Abbreviation: Asia-Pacific Pharmaceutical Announcement No.: 2026-039
Zhejiang Asia-Pacific Pharmaceutical Co., Ltd.
Announcement on Participating in the 2026 Zhejiang Region Listed Companies Online Investor Reception Day and 2025 Annual Performance Briefing
The Company and the entire Board of Directors guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or material omissions.
To further strengthen interactive communication with investors, Zhejiang Asia-Pacific Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") will participate in the "2026 Zhejiang Region Listed Companies Online Investor Reception Day and 2025 Annual Performance Briefing" organized by the Zhejiang Securities Regulatory Bureau and hosted by the Zhejiang Listed Companies Association, undertaken by Shenzhen All-Round Network Co., Ltd. The relevant matters are hereby announced as follows:
This event will be held remotely via the internet. Investors can log in to the "All-Round Roadshow" website (https://rs.p5w.net), follow the WeChat official account "All-Round Finance," or download the All-Round Roadshow APP to participate in this interactive exchange. The event will be held on May 13, 2026 (Wednesday) from 15:00 to 17:00.
At that time, Mr. Qiu Zhongxun, Chairman and General Manager, Mr. Zong Hao, Director and Secretary of the Board, Mr. Chen Xiaobiao, Employee Representative Director and Chief Financial Officer, and Ms. Yu Guihong, Independent Director (personnel may be adjusted under special circumstances), will be online to communicate and interact with investors regarding the Company's 2025 performance, corporate governance, development strategy, operating conditions, financing plans, and other issues of investor concern.